Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results 
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth 
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
ROCKVILLE, Maryland, March 02, 2018 -- The American Kidney Fund (AKF), the nation’s leading nonprofit working on behalf of the 30 million Americans living with kidney disease, today added five new members to its national board of trustees:
|
|||
- Michael W. Flood, managing director and head of private equity of Northleaf Capital Partners in Toronto
- Richard T. Miller, M.D., lead thoracic surgeon and physician-in-chief, Surgery Care Center at Southcoast Hospitals Group in New Bedford, Massachusetts
- Silas P. Norman, M.D., M.P.H., clinical associate professor of internal medicine, Division of Nephrology, University of Michigan Medical School in Ann Arbor
- Lisa A. Robin, chief advocacy officer for the Federation of State Medical Boards in Washington, DC
- Michael R. Vaughan, M.D., director of medical specialties, and practice chief of nephrology at Kaiser Permanente Washington in the Pacific Northwest.
Chaired by 35-year kidney transplant recipient Robert M. Tarola, CPA, CGMA, AKF’s independent, volunteer board is a group of individuals with a broad range of professional backgrounds and personal experiences with kidney disease.
“We are so pleased to welcome our new board members, whose diversity of experience promises to enrich the board’s work in setting AKF's strategic direction for the coming years and providing appropriate oversight to ensure that we have the plans and the resources in place to carry out our vital mission,” said Tarola.
The complete list of trustees and officers, along with their biographies, can be found on AKF’s website.
About the American Kidney Fund
As the nation’s leading nonprofit working on behalf of the 30 million Americans with kidney disease, the American Kidney Fund is dedicated to ensuring that every kidney patient has access to health care, and that every person at risk for kidney disease is empowered to prevent it. AKF provides a complete spectrum of programs and services: prevention outreach, top-rated health educational resources, and direct financial assistance enabling 1 in 5 U.S. dialysis patients to access lifesaving medical care, including dialysis and transplantation. AKF holds the highest ratings from the nation’s charity watchdog groups, including Charity Navigator, which includes AKF on its “top 10” list of nonprofits with the longest track records of outstanding stewardship of the donated dollar, and GuideStar, which has awarded AKF its Platinum Seal of Transparency.
Attachment:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/cb44b379-118f-4782-8e0f-38c102a6b58b
Alice Andors American Kidney Fund 240-292-7053 [email protected]
